what is cdrh doing to accelerate the regulatory pathway for innovative medical technologies?
Published 9 years ago • 766 plays • Length 6:16Download video MP4
Download video MP3
Similar videos
-
1:07:12
fda's cdrh: accelerating upstream medical device innovation
-
1:27
investigational device exemption
-
2:30
role of investigational device exemption (ide)
-
52:39
a roadmap for medical devices: from innovative ideas to the u.s. market
-
1:27:02
medical device innovation
-
16:03
how is cdrh structured?
-
43:31
stanford webinar: regulation & health-eco value assess. - two critical gauges for medtech innovation
-
1:34
how is cdrh encouraging more us-based first-in-human studies?
-
56:55
fda process for medical device startups: an investor's point of view
-
1:29:25
medical device sales strategies
-
1:26:42
harvard i-lab | understanding medical device development
-
3:04
how should innovators determine if their device is regulated?
-
2:51
key differences between 510(k) and pma pathways at the fda
-
18:57
2021 cersi summit - update from cdrh
-
0:46
how branch makes a difference
-
2:17
basics of 510(k) clearance process
-
1:09
classification of a device
-
28:50
closing keynote: cdrh updates
-
2:16
concerns about 510(k) process
-
1:37
structure of fda/cdrh
-
17:39
bringing innovative medical technologies to patients
-
2:55
what is health technology assessment (hta) and which products are most likely to be evaluated?